Baili Pharmaceutical is committed to biopharmaceutical innovation, focusing on addressing unmet clinical needs. With a robust pipeline in small molecule drugs, biologics, and ADCs, we offer end-to-end capabilities from R&D to production and commercialization, delivering life-changing therapies to patients worldwide.
An innovative pharmaceutical company integrating R&D, production and sales
Baili Pharmaceutical is a biopharmaceutical company focused on addressing unmet clinical needs. It specializes in small molecule drugs, biologics, and ADCs, with integrated capabilities spanning R&D, manufacturing, and marketing.
From 2015 to 2023, the company was listed among the "Top 20 Chinese Pharmaceutical Enterprises with the Best R&D Product Pipeline" for nine consecutive years. It was also named one of the "Top 20 Innovative Pharmaceutical Companies" from 2015 to 2022.
The company is recognized as a National High-Tech Enterprise, a National Intellectual Property Demonstration Enterprise, and a Sichuan Province Technology Innovation Demonstration Enterprise.
It operates a National Enterprise Technology Center and a National Postdoctoral Research Workstation.
